Last updated on November 2017

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Evolocumab (AMG 145) on LDL-C in Subjects With Type 2 Diabetes Mellitus and Hypercholesterolemia/Mixed Dyslipidemia Protocol Number (AMG 145/Evolocumab) 20130287


Brief description of study

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Evolocumab (AMG 145) on LDL-C in Subjects With Type 2 Diabetes Mellitus and Hypercholesterolemia/Mixed Dyslipidemia Protocol Number (AMG 145/Evolocumab) 20130287

Detailed Study Description

Receive Evolocumab or Placebo for the treatment of Diabetics with High Cholesterol.

Clinical Study Identifier: TX81978

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Martha Quinones, CRC

Clinical Research of South Florida
Coral Gables, FL USA
  Connect »

Martha Quinones, CRC

Clinical Research of South Florida
Coral Gables, FL USA
  Connect »